You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
CHICAGO – Fresh off a $50 million Series C round of funding, British bioinformatics firm Congenica is expanding into new markets.
GenomeWeb Premium gives you: ✔ Full site access ✔ Interest-based email alerts ✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Moderna says it would be able to quickly update its SARS-CoV-2 vaccine to address new genetic variants if needed, MIT's Technology Review reports.
Johnson & Johnson reports interim results from a Phase 1/2 study of its SARS-CoV-2 vaccine in the New England Journal of Medicine, according to Bloomberg.
Investigators from the World Health Organization have arrived in China to look into the origins of SARS-CoV-2, NPR reports.
In Nature this week: a new method for high-throughput amplicon sequencing, and more.
The composition of the immune infiltrate in the human tumor microenvironment is a critical determinant of disease progression.